Sarcopenia: Pathophysiology and Treatment Strategies

Area of Science:

• Gerontology
• Muscle Physiology
• Metabolic Disorders

Background:

• Sarcopenia is increasingly prevalent in aging and inactive populations, posing significant social health burdens.
• Current research on sarcopenia pathogenesis primarily investigates adipose tissue, myoglobin autophagy, and mitochondrial dysfunction.
• Non-pharmacological interventions remain the primary treatment approach, with no FDA-approved drugs specifically for sarcopenia.

Purpose of the Study:

• To provide a comprehensive summary of sarcopenia's pathophysiology.
• To review existing and potential treatment strategies for sarcopenia.
• To prospect future drug development for sarcopenia.

Main Methods:

• Literature review of sarcopenia pathogenesis.
• Analysis of current non-drug treatment modalities.
• Exploration of emerging therapeutic targets and drug development research.

Main Results:

• Identified key factors in sarcopenia development including adipose tissue changes, autophagy, and mitochondrial issues.
• Highlighted the limitations of current non-drug treatments.
• Outlined potential avenues for future pharmacological interventions.

Conclusions:

• Sarcopenia management requires a multi-faceted approach.
• Further research into novel drug targets is crucial for effective sarcopenia treatment.
• Future drug development holds promise for addressing the growing challenge of sarcopenia.